BROOKS LAB LIMITED Intrinsic Value
BROOKS · Healthcare · Current price ₹69.46
Is BROOKS LAB LIMITED undervalued?
DocStoX estimates the fair value of BROOKS LAB LIMITED at ₹112 per share, versus the current market price of ₹69. That puts the stock about +61.1% below our fair-value estimate, which we read as "Strong Buy". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹48), Relative P/E (₹253), Graham floor (₹88). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹48 (bear) to ₹112 (base) to ₹253 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹69 versus an intrinsic value of ₹112, BROOKS LAB LIMITED currently offers +61.1% of margin.
More on BROOKS LAB LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.